Quick Answer
DarioHealth Corp. reported Total Revenue of $7.39 million for fiscal year 2018.
DarioHealth Corp. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | — |
| Net Income | -$41.71M +2.4% |
-$42.75M +28.1% |
-$59.43M +4.4% |
-$62.19M +19.0% |
-$76.76M -160.7% |
-$29.45M -66.0% |
| Diluted EPS | $10.12 -17.5% |
$12.27 +535.8% |
$1.93 -24.0% |
$2.54 -37.6% |
$4.07 +1.5% |
$4.01 |
| Total Assets | $110.08M -7.4% |
$118.88M +23.3% |
$96.39M -19.1% |
$119.19M +18.3% |
$100.77M +184.6% |
$35.41M +44.1% |
| Cash and Equivalents | $21.80M -21.5% |
$27.76M -24.5% |
$36.80M -25.4% |
$49.36M +37.8% |
$35.81M +25.2% |
$28.59M +40.2% |
| Long-Term Debt | $30.75M +31.0% |
$23.47M -4.6% |
$24.59M +35.8% |
$18.11M | $0.00 | — |
| Stockholders Equity | $67.92M -5.7% |
$72.02M +23.9% |
$58.14M -27.3% |
$80.00M -6.5% |
$85.55M +203.9% |
$28.15M +49.0% |
| R&D Expense | $13.79M -43.0% |
$24.18M +19.4% |
$20.25M +3.0% |
$19.65M +14.1% |
$17.22M +288.4% |
$4.43M +20.1% |
| Operating Income | -$36.66M +36.5% |
-$57.74M -2.8% |
-$56.19M +1.1% |
-$56.81M +25.7% |
-$76.49M -155.8% |
-$29.90M -68.9% |
| Gross Profit | $12.66M -4.5% |
$13.27M +121.7% |
$5.98M -38.0% |
$9.65M +143.6% |
$3.96M +57.7% |
$2.51M -3.2% |
| Shares Outstanding | 6.91M +259.8% |
1.92M -92.9% |
27.19M +5.7% |
25.72M +55.2% |
16.57M +104.1% |
8.12M +263.2% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | June 30, 2019 | $1.65M | -19.8% | -26.4% |
| Net Income | September 30, 2025 | -$10.47M | +15.1% | +19.4% |
| Diluted EPS | September 30, 2025 | $2.96 | -39.7% | +1544.4% |
| Total Assets | September 30, 2025 | $117.73M | +7.1% | +8.7% |
| Cash and Equivalents | September 30, 2025 | $31.91M | +105.2% | +45.3% |
| Long-Term Debt | September 30, 2025 | $30.62M | +51.7% | +0.4% |
| Stockholders Equity | September 30, 2025 | $74.93M | +28.1% | +17.1% |
| R&D Expense | September 30, 2025 | $3.33M | -38.9% | -10.6% |
| Operating Income | September 30, 2025 | -$9.48M | +21.2% | -3.1% |
| Gross Profit | September 30, 2025 | $3.02M | -22.2% | +1.7% |
| Shares Outstanding | September 30, 2025 | 6.77M | -78.4% | -85.1% |
- DarioHealth Corp. reported Total Revenue of $7.39 million for fiscal year 2018.
- DarioHealth Corp. showed an increase of +43.0% in Total Revenue compared to the prior fiscal year.
- DarioHealth Corp. reported Net Income of -$41.71 million for fiscal year 2025.
- DarioHealth Corp. showed an increase of +2.4% in Net Income compared to the prior fiscal year.
- DarioHealth Corp. reported Diluted EPS of $10.12 per share for fiscal year 2025.
- DarioHealth Corp. showed a decrease of -17.5% in Diluted EPS compared to the prior fiscal year.
- DarioHealth Corp. reported Total Assets of $110.08 million for fiscal year 2025.
- DarioHealth Corp. showed a decrease of -7.4% in Total Assets compared to the prior fiscal year.
- DarioHealth Corp. reported Cash and Equivalents of $21.80 million for fiscal year 2025.
- DarioHealth Corp. showed a decrease of -21.5% in Cash and Equivalents compared to the prior fiscal year.
- DarioHealth Corp. reported Long-Term Debt of $30.75 million for fiscal year 2025.
- DarioHealth Corp. showed an increase of +31.0% in Long-Term Debt compared to the prior fiscal year.
- DarioHealth Corp. reported Stockholders Equity of $67.92 million for fiscal year 2025.
- DarioHealth Corp. showed a decrease of -5.7% in Stockholders Equity compared to the prior fiscal year.
- DarioHealth Corp. reported R&D Expense of $13.79 million for fiscal year 2025.
- DarioHealth Corp. showed a decrease of -43.0% in R&D Expense compared to the prior fiscal year.
- DarioHealth Corp. reported Operating Income of -$36.66 million for fiscal year 2025.
- DarioHealth Corp. showed an increase of +36.5% in Operating Income compared to the prior fiscal year.
- DarioHealth Corp. reported Gross Profit of $12.66 million for fiscal year 2025.
- DarioHealth Corp. showed a decrease of -4.5% in Gross Profit compared to the prior fiscal year.
- DarioHealth Corp. reported Shares Outstanding of 6.91 million shares for fiscal year 2025.
- DarioHealth Corp. showed an increase of +259.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: